12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Fosrenol lanthanum carbonate regulatory update

Shire said the Swedish Medical Products Agency approved an oral powder formulation of Fosrenol lanthanum carbonate. The product was approved via the decentralized procedure, with Sweden acting as the reference member...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >